: Introduction: A genetic algorithm (GA)-based approach was designed to predict drug-drug interactions (DDIs) triggered by cytochrome P450 3A (CYP3A) inhibition or induction in horses. Methods: Area under the concentration-time curve ratios (AUCRs), obtained from published in vivo DDI studies in horses, were used to compute the following parameters: (1) the contribution ratio (CR), i.e., the fraction of the substrate dose metabolized via the CYP3A pathway, and (2) the interacting drug's inhibitory potency or inducing efficacy (IR or IC, respectively). Results: AUCRs for 9 substrates, 12 inhibitors, and 1 inducer of equine CYP3A were predicted and validated with the developed method. More than 96% of predictions fell within the commonly accepted range of 50-200% of observed values. Conclusions: The proposed GA-based method may be a useful tool to estimate possible clinically relevant DDIs when co-administration of a CYP3A substrate and a CYP3A-interacting drug is anticipated.

A Genetic Algorithm-Based Approach for Quantitative Prediction of Drug-Drug Interactions Caused by Cytochrome P450 3A Inhibition or Induction in Horses

Di Paolo V.
Conceptualization
;
Dacasto M.
Writing – Review & Editing
;
Quintieri L.
Writing – Original Draft Preparation
;
Capolongo F.
Resources
2026

Abstract

: Introduction: A genetic algorithm (GA)-based approach was designed to predict drug-drug interactions (DDIs) triggered by cytochrome P450 3A (CYP3A) inhibition or induction in horses. Methods: Area under the concentration-time curve ratios (AUCRs), obtained from published in vivo DDI studies in horses, were used to compute the following parameters: (1) the contribution ratio (CR), i.e., the fraction of the substrate dose metabolized via the CYP3A pathway, and (2) the interacting drug's inhibitory potency or inducing efficacy (IR or IC, respectively). Results: AUCRs for 9 substrates, 12 inhibitors, and 1 inducer of equine CYP3A were predicted and validated with the developed method. More than 96% of predictions fell within the commonly accepted range of 50-200% of observed values. Conclusions: The proposed GA-based method may be a useful tool to estimate possible clinically relevant DDIs when co-administration of a CYP3A substrate and a CYP3A-interacting drug is anticipated.
2026
File in questo prodotto:
Non ci sono file associati a questo prodotto.
Pubblicazioni consigliate

I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.

Utilizza questo identificativo per citare o creare un link a questo documento: https://hdl.handle.net/11577/3609038
Citazioni
  • ???jsp.display-item.citation.pmc??? ND
  • Scopus ND
  • ???jsp.display-item.citation.isi??? 0
  • OpenAlex ND
social impact